We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Turning Point Brands Inc | NYSE:TPB | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.16 | 0.49% | 32.73 | 34.00 | 32.35 | 33.71 | 176,173 | 01:00:00 |
From May 2021 to May 2024
By Michael Dabaie
Turning Point Brands Inc. said the U.S. Food and Drug Administration denied the company's application to market some of its vapor products.
Turning Point said it will continue to engage with the FDA and other stakeholders as it considers options, including a formal appeal of the decision and potential legal relief.
"While we believe the FDA's current conclusion is misguided, we will continue our dialogue with the agency in search of a path forward," said Chief Executive Larry Wexler.
Turning Point's premarket tobacco product application included an in-depth toxicological review, a clinical study, and studies on patterns and likelihood of use, the company said.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
September 17, 2021 08:21 ET (12:21 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Turning Point Brands Chart |
1 Month Turning Point Brands Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
